A comprehensive review in the Texas
Heart Institute Journal covers standard indications (ischemic and
non-ischemic cardiomyopathy), unusual indications (infiltrative
diseases, channelopathies) and controversies (timing of implantation
after MI or onset of HF). Free full text available here.
No comments:
Post a Comment